Real-world evidence indicates romosozumab use is associated with a greater reduction in osteoporotic fractures than PTH (1-34) analogs in women.

Biol Sex Differ · 2026 · PMC12870266 · PMID 41484973

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a nonsignificant trendno p-value reported

ROMO was also associated with a lower risk of hypercalcemia (HR: 0.707, 95% CI: 0.511–0.977) and a nonsignificant trend toward higher hypocalcemia (HR: 1.655, 95% CI: 0.892–3.071).

also in 5,406 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.